We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roxane Says Shared REMS Work, Dismissing Prometheus’ Concerns
While each risk evaluation and mitigation strategy (REMS) presents its own set of challenges, it doesn’t preclude the successful establishment of shared systems, a representative of Roxane Laboratories said July 10 in the generic drugmaker’s first public comments on the subject.